期刊文献+

单倍体相合造血干细胞移植后细胞免疫重建的动力学的临床研究 被引量:2

原文传递
导出
摘要 异基因造血干细胞移植(allo-HSCT)属于造血免疫细胞移植,NK细胞是HSCT后最早开始恢复的淋巴细胞亚群.NK细胞受体分子(KIR)在HSCT中与移植物抗宿主病(GVHD)发生以及与移植后复发的关系引人注目[1].异基因供者移植物中的CD4+ CD25+细胞群(Tmg)细胞比例与GVHD发生有关[2-3].我们前期的实验研究发现供者未成熟DC细胞可以防止骨髓移植后GVHD发生而不减弱移植物抗白血病(GVL)效应[4].
出处 《中华血液学杂志》 CAS CSCD 北大核心 2012年第1期53-55,共3页 Chinese Journal of Hematology
基金 国家自然科学基金(30170395)
  • 相关文献

参考文献13

  • 1段连宁,陈纯,黄绍良,方建培,魏菁,包蓉,李艳,韩红星,李树浓.免疫活性细胞表达杀伤细胞抑制性受体与造血干细胞移植后移植物抗宿主病的关系(英文)[J].中国实验血液学杂志,2003,11(6):625-632. 被引量:6
  • 2段连宁,丁丽,闫洪敏,薛梅,刘静,朱玲,王恒湘,纪树荃.单倍体相合骨髓移植后CD4^+CD25^+ T细胞免疫恢复的临床研究[J].中国实验血液学杂志,2010,18(1):177-180. 被引量:5
  • 3Taylor PA,Lees C J,Blasar BR.The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.Blood,2002,99:3493-3499.
  • 4Xu L,Duan L,Cao K,et al.Predominant immature CD8alpha+dendritic cells prevent graft-vs.-host disease but do not increase the risk of leukemia recurrence.Eur J Haematol,2007,78:235-245.
  • 5Ji SQ,Chen HR,Wang HX,et al.G-CSF-primed haploidenticalmarrow transplantation without ex vivo T cell depletion:an excellent alternative for high risk leukemia.Bone Marrow Transplant,2002,30:861-866.
  • 6Ruggeri L,Mancusi A,Burchielli E,et al.Natural killer cell alloreactivity and hapo-identical hematopoietic transplantation.Cytotherapy,2006,8:554-558.
  • 7Stem M,de Angelis C,Urbani E,et al.Natural killer-cell KIR repertoire reconstitution after haploidentical SCT. Bone Marrow Transplant,2010,45:1607-1610.
  • 8Ruggeri L,Capanni M,Casucci M,et al.Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation.Blood,1999,94:333-339.
  • 9Zhao XY,Huang X J,Liu KY,et al.Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome. Biol Blood Marrow Transplant,2007,13:734-744.
  • 10Triplett BM,Horwitz EM,Lyengar R,et al.Effects of activating NK cell receptor expression and NK cell reconstitution on the outcome of unrelated donor hematopoietic cell transplantation for hematologic malignancies.Leukemia,2009,23:1278-1287.

二级参考文献12

  • 1Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4 ( + ) CD25 ( + ) immune regulatory cells inhibits graft-versus-host disease lethality. Blood, 2002 ;99 ( 10 ) : 3493 - 3499.
  • 2von Boehmer H. Mechanisms of suppression by suppressor T cell. Nat Immunol,2005,6 (4) : 338 - 344.
  • 3Eimann J, Hoffmann P, Edinger M, et al. Only the CD62L^+ subpopulation of CD4 ^+ CD25^ + regulatory T cells protects from lethal acute GVHD. Blood ,2005 ; 105 (5) :2220 - 2226.
  • 4Stanzani M, Martins SL, Saliba RM, et al. CD25 expression on donor CD4^ + or CD8^+ T ceils is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplan- tation in humans. Blood, 2004;103(3) :1140 -1146.
  • 5Meignin V, Peffault de Latour R, Zuber J, et al. Numbers of Foxp3-expressing CD4^ + CD25^high T cells do not correlate with the establishment of long-term tolerance sfter allogeneic stem cell transplantation. Exp Hematol,2005 ;33 ( 8 ) :894 - 900.
  • 6Clark FJ, Gregg R, PiperK, et al. Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4 ^+ CD25^high regulatory T cells. Blood, 2004 ; 103 ( 3 ) : 2410 - 2416.
  • 7Edinger M, Hoffmann P, Eimann J, et al. CD4^+ CD25^+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med, 2003 ;9(9) :1144 - 1150.
  • 8Jones SC, Murphy GF, Komgold R. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4CD25 T ceils to allow an effective graft-versus-leukemia response. Biol Blood Marrow Transplant, 2003 ;9(4) :243 -256.
  • 9Nadal E, Garin M, Kaeda J, et al. Increased frequencies of CD4^+ CD25 ( high ) T ( regs ) correlated with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Leukemia, 2007 ;21 (3) :472 -479.
  • 10陈纯,段连宁,黄绍良,李树浓,魏菁.人脐血T/NK细胞KIR分子表达的初步探讨[J].中山医科大学学报,2002,23(1):67-69. 被引量:5

共引文献9

同被引文献25

  • 1蒋盼,汪华.自然杀伤细胞表面受体NKp46的研究进展[J].中华临床医师杂志(电子版),2011,5(22):6711-6714. 被引量:5
  • 2于津浦,曹水,辛宁,安秀梅,齐静,任秀宝.低剂量氟达拉滨、环磷酰胺联合供者NK细胞作为非清髓性预处理用于小鼠单倍相合造血干细胞移植[J].中国实验血液学杂志,2007,15(5):1013-1018. 被引量:2
  • 3Walzer T, BI 6 ry M, Chaix J, et aL Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46 [ J ] . Proc Natl Acad Sci U S A, 2007, 104 ( 9 ) : 3384-3389.
  • 4Storek J, Dawson MA, Storer B, et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation [ J] . Blood, 2001, 97 ( 11 ) : 3380-3389.
  • 5Caligiuri MA. Human natural killer cells[ J ]. Blood, 2008, 112( 3 ): 461-469.
  • 6Locatelli F, Pende D, Mingari MC, et al. Cellular and molecular basis of baploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias : role of alloreactive NK cells [ J ] . Front Immunol, 2013, 4 : 15.
  • 7Lob J, Chu DT, O' guin AK, et al. Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegaovirus infection in the spleen and liver [ J ]. J Virol, 2005, 79 ( 1 ) : 661-667.
  • 8Arase H, Mocarski ES, Campbell AE, et al. Direct recognition ofcytomegalovirus by activating and inhibitory NK cell receptors [ J ] . Science, 2002, 296 ( 5571 ) : 1323-1326.
  • 9Sanos SL, Diefenbach A. Isolation of NK ceils and NK-like cells from the intestinal lamina propria'[ J ] . Methods Mol Biol, 2010, 612 : 505-517.
  • 10Small CL, Shaler CR, Mccormick S, et al. Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung [ J] . J Immunol, 2010, 184 ( 4 ) : 2048-2056.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部